Study: Celiac Patients More Likely to Develop A-fib
A new study has found that there is a link between Celiac patients and atrial fibrillation. A team of researchers discovered that there are many inflammatory markers that are risk...
EMA Has Restricted Multaq Use; Will FDA Follow Suit?
At the end of September, the European Medicines Agency (EMA) announced that it is going to restrict Multaq use to patients with paroxysmal or persistent atrial fibrillation due to the...
European Medicines Agency: Multaq Should Only be Used Under Certain Conditions
On Sept. 2, Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has confirmed that there is a positive benefit-risk balance...
FDA Still Reviewing Multaq as More and More Doctors Stop Using It
The FDA announced on Sept. 21 that it will continue to review the drug Multaq. This announcement coincides with the fact that more and more doctors and specialists are reporting...
Sanofi CEO Believes the Drug Industry is Undervalued
The chief executive officer of Sanofi, Chris Viehbacher, recently stated that he believes that the pharmaceutical industry is undervalued. As his company is currently coping with the patent expiry of...